Your browser doesn't support javascript.
loading
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.
Watanabe, Tsubasa; Firat, Elke; Scholber, Jutta; Gaedicke, Simone; Heinrich, Corinne; Luo, Ren; Ehrat, Nicolas; Multhoff, Gabriele; Schmitt-Graeff, Annette; Grosu, Anca-Ligia; Abdollahi, Amir; Hassel, Jessica C; von Bubnoff, Dagmar; Meiss, Frank; Niedermann, Gabriele.
Afiliação
  • Watanabe T; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Firat E; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.
  • Scholber J; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Gaedicke S; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Heinrich C; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Luo R; Department of Dermatology and Venerology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Ehrat N; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Multhoff G; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Schmitt-Graeff A; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Grosu AL; Department of Radiation Oncology, Technical University Munich, Munich, Germany.
  • Abdollahi A; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center, Heidelberg, Germany.
  • Hassel JC; Institute of Pathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • von Bubnoff D; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
  • Meiss F; German Cancer Consortium (DKTK), Partner Site Freiburg, and German Cancer Research Center, Heidelberg, Germany.
  • Niedermann G; Department of Radiation Oncology, Heidelberg University Medical School, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCOR), Heidelberg, Germany.
Cancer Immunol Immunother ; 69(9): 1823-1832, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32350591
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Melanoma Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Melanoma Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article